3992446eaf515fdd2a4fbcafea7b714b  289147.pdf
bec0a97c971fa635f1231ee6449a34801961dd56  289147.pdf
e3184980303b9bb5680ee8a9f83f62bf8521248f57f8364418cbf661275d4d83  289147.pdf

Title:          GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
Subject:        British Journal of Cancer 117, 767 (2017). doi:10.1038/bjc.2017.252
Author:         J Mora
Creator:        Arbortext Advanced Print Publisher 9.0.226/W
Producer:       Acrobat Distiller 10.1.8 (Windows)
CreationDate:   Fri Aug 11 14:48:52 2017 CEST
ModDate:        Thu Aug 17 12:32:42 2017 CEST
Tagged:         no
UserProperties: no
Suspects:       no
Form:           AcroForm
JavaScript:     no
Pages:          8
Encrypted:      no
Page size:      595.276 x 790.866 pts
Page rot:       0
File size:      521601 bytes
Optimized:      yes
PDF version:    1.6


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
IDAMDI+AdvOT3b9b4d35                 Type 1C           WinAnsi          yes yes no     297  0
IDALIB+AdvOTa851a675.B               Type 1C           WinAnsi          yes yes no     265  0
IDALJC+AdvOTb0d2661a                 Type 1C           WinAnsi          yes yes no     266  0
IDALJD+AdvOTf1c06d06.I               Type 1C           Custom           yes yes no     271  0
IDALKD+AdvOTdadbfad7.B               Type 1C           WinAnsi          yes yes no     273  0
IDALKE+AdvOT0906c96e                 Type 1C           Custom           yes yes no     274  0
IDALKF+AdvEls-ent4                   Type 1C           WinAnsi          yes yes no     275  0
IDALLG+AdvPi1                        Type 1C           WinAnsi          yes yes no     281  0
IDALLH+AdvEls-ent5                   Type 1C           WinAnsi          yes yes no     285  0
IDALLI+AdvP4C4E74                    Type 1C           Custom           yes yes yes    286  0
IDALMJ+AdvEls-ent3                   Type 1C           WinAnsi          yes yes no     292  0
IDALMK+AdvOTfe809cc4                 Type 1C           WinAnsi          yes yes no     293  0
IDAMHH+AdvOT1ef757c0                 Type 1C           Custom           yes yes yes    121  0
IDAMHI+AdvOT7d6df7ab.I               Type 1C           Custom           yes yes yes    122  0
IDANBG+AdvOTb65e897d.B               Type 1C           Custom           yes yes yes    123  0
IDANGF+AdvOT1916b968.BI              Type 1C           WinAnsi          yes yes no     132  0
IDAPDL+Helvetica                     Type 1C           WinAnsi          yes yes no     133  0
IDBBMM+Symbol                        Type 1C           Custom           yes yes yes    138  0
IDBBNM+Helvetica-Bold                Type 1C           WinAnsi          yes yes no     139  0
IDBDDF+Helvetica-Oblique             Type 1C           WinAnsi          yes yes no     146  0


Jhove (Rel. 1.28.0, 2023-05-18)
 Date: 2024-02-21 02:54:30 CET
 RepresentationInformation: 289147.pdf
  ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16)
  LastModified: 2024-02-20 14:12:02 CET
  Size: 521601
  Format: PDF
  Version: 1.6
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 318
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    PageLayout: SinglePage
    PageMode: UseNone
    Outlines: 
     Item: 
      Title: title_link
      Destination: title_link
      Children: 
       Item: 
        Title: PATIENTS AND METHODS
        Destination: A1
        Children: 
         Item: 
          Title: Patients
          Destination: B1
         Item: 
          Title: Study design
          Destination: B2
         Item: 
          Title: Statistical analysis
          Destination: B3
       Item: 
        Title: RESULTS
        Destination: A2
        Children: 
         Item: 
          Title: Patient characteristics
          Destination: B4
         Item: 
          Title: Outcome
          Destination: B5
       Item: 
        Title: Table 1 
        Destination: tab_bktbltbl1
       Item: 
        Title: Figure™1Treatment details and road map.The mP6 regimen consisted of cycles 1, 2 and 4 with cyclophosphamide 4.2thinspgthinspm-2, doxorubicin 75thinspmgthinspm-2 and vincristine 2thinspmgthinspm-2 (CDV); and cycles 3 and 5 with ifosfamide 9thinspgthinspm-2
        Destination: fig_bkfigfig1
       Item: 
        Title: Figure™2Kaplan-Meier plots of EFS and OS.(A) All patients, (B) stratified by standard and high risk and (C) stratified by age lt18 and ges18
        Destination: fig_bkfigfig2
        Children: 
         Item: 
          Title: The GsolD regimen
          Destination: B6
         Item: 
          Title: The mP6 regimen
          Destination: B7
         Item: 
          Title: Local control measures
          Destination: B8
         Item: 
          Title: Toxicity
          Destination: B9
       Item: 
        Title: DISCUSSION
        Destination: A3
       Item: 
        Title: Figure™3Multivariate survival analyses.(A) Kaplan-Meier plot of OS stratified according to the combination of age and risk groups, (B) Cox model for OS: hazard ratios, 95percnt confidence intervals and statistical significance
        Destination: fig_bkfigfig3
       Item: 
        Title: This work was supported by Fundación FERO (primera beca de Oncología traslacional esponsorizada por la Fundació Josep Botet); Instituto de Salud Carlos III, Ministerio de sanidad y consumo; Fondo de investigación sanitaria (TRA-130 2009 to JM); Asociación
        Destination: A4
       Item: 
        Title: ACKNOWLEDGEMENTS
        Destination: M1
       Item: 
        Title: Table 2 
        Destination: tab_bktbltbl2
       Item: 
        Title: This study was presented in part at the oral sarcoma session of the American Society of Clinical Oncology Annual Meeting, Chicago, IL, 5 June 2016.This work is published under the standard license to publish agreement. After 12 months the work will become
        Destination: A5
       Item: 
        Title: Author contributions
        Destination: A6
       Item: 
        Title: A7
        Destination: A7
   Info: 
    Title: GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
    Author: J Mora
    Subject: British Journal of Cancer 117, 767 (2017). doi:10.1038/bjc.2017.252
    Creator: Arbortext Advanced Print Publisher 9.0.226/W
    Producer: Acrobat Distiller 10.1.8 (Windows)
    CreationDate: Fri Aug 11 14:48:52 CEST 2017
    ModDate: Thu Aug 17 13:02:42 CEST 2017
   ID: 0x6d251dcb639dc0c7d8058f9d9044d614, 0x9bde30de0f7dac4295ea2270a94046fe
   Filters: 
    FilterPipeline: FlateDecode
    FilterPipeline: DCTDecode
   Images: 
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 2606
      ImageHeight: 970
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 1352
      ImageHeight: 963
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 1273
      ImageHeight: 945
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 1273
      ImageHeight: 945
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 1275
      ImageHeight: 945
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 1276
      ImageHeight: 945
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 1272
      ImageHeight: 946
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 937
      ImageHeight: 738
      BitsPerSample: 8
      BitsPerSampleUnit: integer
   Fonts: 
    Type1: 
     Font: 
      BaseFont: IDALMJ+AdvEls-ent3
      FontSubset: true
      FirstChar: 114
      LastChar: 114
      FontDescriptor: 
       FontName: IDALMJ+AdvEls-ent3
       Flags: Nonsymbolic
       FontBBox: 0, -208, 1083, 739
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDANGF+AdvOT1916b968.BI
      FontSubset: true
      FirstChar: 78
      LastChar: 78
      FontDescriptor: 
       FontName: IDANGF+AdvOT1916b968.BI
       Flags: Nonsymbolic
       FontBBox: -156, -270, 1187, 937
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDALMK+AdvOTfe809cc4
      FontSubset: true
      FirstChar: 37
      LastChar: 151
      FontDescriptor: 
       FontName: IDALMK+AdvOTfe809cc4
       Flags: Nonsymbolic
       FontBBox: -166, -281, 1000, 916
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDAPDL+Helvetica
      FontSubset: true
      FirstChar: 32
      LastChar: 150
      FontDescriptor: 
       FontName: IDAPDL+Helvetica
       Flags: Nonsymbolic
       FontBBox: -166, -225, 1000, 931
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDAMDI+AdvOT3b9b4d35
      FontSubset: true
      FirstChar: 45
      LastChar: 150
      FontDescriptor: 
       FontName: IDAMDI+AdvOT3b9b4d35
       Flags: Nonsymbolic
       FontBBox: -156, -281, 1031, 916
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDALIB+AdvOTa851a675.B
      FontSubset: true
      FirstChar: 40
      LastChar: 121
      FontDescriptor: 
       FontName: IDALIB+AdvOTa851a675.B
       Flags: Nonsymbolic
       FontBBox: -156, -250, 1125, 947
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDALJC+AdvOTb0d2661a
      FontSubset: true
      FirstChar: 42
      LastChar: 152
      FontDescriptor: 
       FontName: IDALJC+AdvOTb0d2661a
       Flags: Nonsymbolic
       FontBBox: -156, -250, 1000, 927
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDBBMM+Symbol
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: IDBBMM+Symbol
       Flags: Symbolic
       FontBBox: -180, -293, 1090, 1010
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: IDBBNM+Helvetica-Bold
      FontSubset: true
      FirstChar: 65
      LastChar: 67
      FontDescriptor: 
       FontName: IDBBNM+Helvetica-Bold
       Flags: Nonsymbolic, ForceBold
       FontBBox: -170, -228, 1003, 962
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDALJD+AdvOTf1c06d06.I
      FontSubset: true
      FirstChar: 25
      LastChar: 180
      FontDescriptor: 
       FontName: IDALJD+AdvOTf1c06d06.I
       Flags: Nonsymbolic
       FontBBox: -166, -270, 1031, 927
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: IDALKD+AdvOTdadbfad7.B
      FontSubset: true
      FirstChar: 37
      LastChar: 150
      FontDescriptor: 
       FontName: IDALKD+AdvOTdadbfad7.B
       Flags: Nonsymbolic
       FontBBox: -156, -250, 1156, 937
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDALKE+AdvOT0906c96e
      FontSubset: true
      FirstChar: 25
      LastChar: 180
      FontDescriptor: 
       FontName: IDALKE+AdvOT0906c96e
       Flags: Nonsymbolic
       FontBBox: -166, -250, 1000, 927
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
     Font: 
      BaseFont: IDBDDF+Helvetica-Oblique
      FontSubset: true
      FirstChar: 112
      LastChar: 112
      FontDescriptor: 
       FontName: IDBDDF+Helvetica-Oblique
       Flags: Nonsymbolic, Italic
       FontBBox: -170, -225, 1116, 931
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDALKF+AdvEls-ent4
      FontSubset: true
      FirstChar: 111
      LastChar: 112
      FontDescriptor: 
       FontName: IDALKF+AdvEls-ent4
       Flags: Nonsymbolic
       FontBBox: 0, -343, 1166, 1218
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDALLG+AdvPi1
      FontSubset: true
      FirstChar: 52
      LastChar: 109
      FontDescriptor: 
       FontName: IDALLG+AdvPi1
       Flags: Serif, Nonsymbolic
       FontBBox: 13, -323, 958, 824
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDAMHH+AdvOT1ef757c0
      FontSubset: true
      FirstChar: 26
      LastChar: 180
      FontDescriptor: 
       FontName: IDAMHH+AdvOT1ef757c0
       Flags: Serif, Symbolic
       FontBBox: -135, -250, 1010, 854
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: IDAMHI+AdvOT7d6df7ab.I
      FontSubset: true
      FirstChar: 49
      LastChar: 133
      FontDescriptor: 
       FontName: IDAMHI+AdvOT7d6df7ab.I
       Flags: Serif, Symbolic
       FontBBox: -156, -250, 1000, 854
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: IDANBG+AdvOTb65e897d.B
      FontSubset: true
      FirstChar: 46
      LastChar: 121
      FontDescriptor: 
       FontName: IDANBG+AdvOTb65e897d.B
       Flags: Serif, Symbolic
       FontBBox: -125, -250, 1052, 854
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: IDALLH+AdvEls-ent5
      FontSubset: true
      FirstChar: 88
      LastChar: 88
      FontDescriptor: 
       FontName: IDALLH+AdvEls-ent5
       Flags: Serif, Nonsymbolic
       FontBBox: 9, -343, 1166, 791
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: IDALLI+AdvP4C4E74
      FontSubset: true
      FirstChar: 2
      LastChar: 254
      FontDescriptor: 
       FontName: IDALLI+AdvP4C4E74
       Flags: Symbolic
       FontBBox: -20, -958, 1114, 770
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 4.0-c316 44.253921, Sun Oct 01 2006 17:14:39">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about="doi:10.1038/bjc.2017.252"
            xmlns:dc="http://purl.org/dc/elements/1.1/">
         <dc:format>application/pdf</dc:format>
         <dc:identifier>&#xA;            doi:10.1038/bjc.2017.252</dc:identifier>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>J Mora</rdf:li>
               <rdf:li>A Casta&amp;ntilde;eda</rdf:li>
               <rdf:li>S Perez-Jaume</rdf:li>
               <rdf:li>A Lopez-Pousa</rdf:li>
               <rdf:li>E Maradiegue</rdf:li>
               <rdf:li>C Valverde</rdf:li>
               <rdf:li>J Martin-Broto</rdf:li>
               <rdf:li>X Garcia del Muro</rdf:li>
               <rdf:li>O Cruz</rdf:li>
               <rdf:li>J Cruz</rdf:li>
               <rdf:li>J Martinez-Trufero</rdf:li>
               <rdf:li>J Maurel</rdf:li>
               <rdf:li>M A Vaz</rdf:li>
               <rdf:li>E de Alava</rdf:li>
               <rdf:li>C de Torres</rdf:li>
               <rdf:li> </rdf:li>
            </rdf:Seq>
         </dc:creator>
         <dc:description>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">British Journal of Cancer 117, 767 (2017). doi:10.1038/bjc.2017.252</rdf:li>
            </rdf:Alt>
         </dc:description>
         <dc:publisher>
            <rdf:Bag>
               <rdf:li>Nature Publishing Group</rdf:li>
            </rdf:Bag>
         </dc:publisher>
         <dc:rights>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">© 2017 Cancer Research UK</rdf:li>
            </rdf:Alt>
         </dc:rights>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)</rdf:li>
            </rdf:Alt>
         </dc:title>
      </rdf:Description>
      <rdf:Description rdf:about="doi:10.1038/bjc.2017.252"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <pdf:Producer>Acrobat Distiller 10.1.8 (Windows)</pdf:Producer>
      </rdf:Description>
      <rdf:Description rdf:about="doi:10.1038/bjc.2017.252"
            xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">
         <prism:copyright>&#xA;            ©  </prism:copyright>
         <prism:doi>10.1038/bjc.2017.252</prism:doi>
         <prism:eIssn>1532-1827</prism:eIssn>
         <prism:endingPage>774</prism:endingPage>
         <prism:issn>0007-0920</prism:issn>
         <prism:number>6</prism:number>
         <prism:publicationName/>
         <prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
         <prism:startingPage>767</prism:startingPage>
         <prism:volume>117</prism:volume>
         <prism:publicationDate>
            <rdf:Bag>
               <rdf:li>2017-08-08</rdf:li>
            </rdf:Bag>
         </prism:publicationDate>
         <prism:url>
            <rdf:Bag>
               <rdf:li>&#xA;                http://dx.doi.org/10.1038/bjc.2017.252</rdf:li>
            </rdf:Bag>
         </prism:url>
      </rdf:Description>
      <rdf:Description rdf:about="doi:10.1038/bjc.2017.252"
            xmlns:xap="http://ns.adobe.com/xap/1.0/">
         <xap:CreateDate>2017-08-11T12:48:52Z</xap:CreateDate>
         <xap:CreatorTool>Arbortext Advanced Print Publisher 9.0.226/W</xap:CreatorTool>
         <xap:Label>British Journal of Cancer 117, 767 (2017). doi:10.1038/bjc.2017.252</xap:Label>
         <xap:MetadataDate>2017-08-17T16:02:42+05:30</xap:MetadataDate>
         <xap:ModifyDate>2017-08-17T16:02:42+05:30</xap:ModifyDate>
         <xap:Identifier>
            <rdf:Bag>
               <rdf:li>&#xA;                doi:10.1038/bjc.2017.252</rdf:li>
            </rdf:Bag>
         </xap:Identifier>
      </rdf:Description>
      <rdf:Description rdf:about="doi:10.1038/bjc.2017.252"
            xmlns:xapRights="http://ns.adobe.com/xap/1.0/rights/">
         <xapRights:Marked>True</xapRights:Marked>
      </rdf:Description>
      <rdf:Description rdf:about="doi:10.1038/bjc.2017.252"
            xmlns:xapMM="http://ns.adobe.com/xap/1.0/mm/">
         <xapMM:DocumentID>uuid:6a966638-7ad4-412e-ad70-84a6d43aa22d</xapMM:DocumentID>
         <xapMM:InstanceID>uuid:0db8eb09-fc07-4445-80a7-fbda810b627b</xapMM:InstanceID>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 177, 106, 290, 114
      Annotation: 
       Subtype: Link
       Rect: 43, 23, 118, 32
     Thumb: true
    Page: 
     Label: 2
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 237, 679, 291, 688
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 43, 669, 61, 678
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 66, 669, 142, 678
       Destination: 111
      Annotation: 
       Subtype: Link
       Rect: 236, 648, 291, 657
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 43, 637, 61, 647
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 175, 595, 261, 605
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 120, 564, 235, 573
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 46, 533, 121, 542
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 118, 491, 182, 500
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 187, 480, 253, 490
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 113, 439, 176, 448
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 110, 428, 128, 437
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 167, 376, 227, 385
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 173, 344, 191, 354
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 84, 313, 145, 322
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 130, 292, 189, 301
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 196, 292, 264, 301
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 271, 292, 291, 301
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 43, 282, 82, 291
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 87, 282, 156, 291
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 128, 93, 194, 103
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 303, 611, 334, 621
       Destination: 38
      Annotation: 
       Subtype: Link
       Rect: 414, 517, 479, 527
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 515, 507, 549, 516
       Destination: 38
      Annotation: 
       Subtype: Link
       Rect: 306, 251, 397, 260
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 506, 240, 551, 250
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 303, 230, 321, 239
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 325, 230, 363, 239
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 367, 230, 479, 239
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 414, 198, 454, 208
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 358, 178, 403, 187
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 306, 157, 425, 166
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 357, 104, 431, 114
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 372, 17, 446, 26
     Thumb: true
    Page: 
     Label: 3
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 88, 462, 117, 472
       Destination: 38
      Annotation: 
       Subtype: Link
       Rect: 208, 441, 286, 451
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 84, 219, 125, 228
       Destination: 53
      Annotation: 
       Subtype: Link
       Rect: 140, 208, 177, 218
       Destination: 53
      Annotation: 
       Subtype: Link
       Rect: 43, 125, 79, 134
       Destination: 53
      Annotation: 
       Subtype: Link
       Rect: 454, 73, 493, 82
       Destination: 66
      Annotation: 
       Subtype: Link
       Rect: 43, 17, 118, 26
     Thumb: true
    Page: 
     Label: 4
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 123, 124, 161, 134
       Destination: 66
      Annotation: 
       Subtype: Link
       Rect: 372, 17, 446, 26
     Thumb: true
    Page: 
     Label: 5
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 353, 171, 381, 180
       Destination: 78
      Annotation: 
       Subtype: Link
       Rect: 350, 62, 413, 71
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 43, 17, 118, 26
     Thumb: true
    Page: 
     Label: 6
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 398, 731, 511, 741
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 482, 711, 549, 720
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 303, 700, 386, 709
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 394, 700, 465, 709
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 474, 700, 549, 709
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 303, 690, 416, 699
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 422, 690, 512, 699
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 306, 669, 366, 678
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 371, 669, 442, 678
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 447, 669, 511, 678
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 384, 595, 462, 605
       Destination: 111
      Annotation: 
       Subtype: Link
       Rect: 469, 595, 546, 605
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 486, 533, 546, 542
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 306, 512, 374, 521
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 380, 512, 439, 521
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 445, 512, 516, 521
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 464, 460, 549, 469
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 303, 449, 395, 458
       Destination: 111
      Annotation: 
       Subtype: Link
       Rect: 400, 449, 473, 458
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 478, 449, 549, 458
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 303, 439, 362, 448
       Destination: 105
      Annotation: 
       Subtype: Link
       Rect: 432, 324, 529, 333
       Destination: 111
      Annotation: 
       Subtype: Link
       Rect: 401, 229, 499, 239
       Destination: 111
      Annotation: 
       Subtype: Link
       Rect: 372, 17, 446, 26
     Thumb: true
    Page: 
     Label: 7
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 347, 511, 406, 519
      Annotation: 
       Subtype: Link
       Rect: 315, 147, 398, 155
      Annotation: 
       Subtype: Link
       Rect: 43, 17, 118, 26
     Thumb: true
    Page: 
     Label: 8
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 372, 17, 446, 26
     Thumb: true
  Checksum: 1769005d
   Type: CRC32
  Checksum: 3992446eaf515fdd2a4fbcafea7b714b
   Type: MD5
  Checksum: bec0a97c971fa635f1231ee6449a34801961dd56
   Type: SHA-1
  Checksum: e3184980303b9bb5680ee8a9f83f62bf8521248f57f8364418cbf661275d4d83
   Type: SHA-256